Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6014931 [patent_doc_number] => 20020102231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Therapeutic uses of PAF-AH products in diabetes' [patent_app_type] => new [patent_app_number] => 09/774414 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7162 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102231.pdf [firstpage_image] =>[orig_patent_app_number] => 09774414 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/774414
Therapeutic uses of PAF-AH products in diabetes Jan 30, 2001 Abandoned
Array ( [id] => 6062961 [patent_doc_number] => 20020031543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Adjuvant comprising pulmonary surfactant' [patent_app_type] => new [patent_app_number] => 09/772768 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6256 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031543.pdf [firstpage_image] =>[orig_patent_app_number] => 09772768 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/772768
Adjuvant comprising pulmonary surfactant Jan 29, 2001 Abandoned
Array ( [id] => 6541697 [patent_doc_number] => 20020110558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases' [patent_app_type] => new [patent_app_number] => 09/770002 [patent_app_country] => US [patent_app_date] => 2001-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3567 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110558.pdf [firstpage_image] =>[orig_patent_app_number] => 09770002 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/770002
Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases Jan 24, 2001 Abandoned
09/700200 Antibodies to dendritic cells and human dendritic cell populations and uses thereof Jan 22, 2001 Abandoned
Array ( [id] => 6908051 [patent_doc_number] => 20010010818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Methods and formulations for reducing circulating antibodies' [patent_app_type] => new [patent_app_number] => 09/766365 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20010010818.pdf [firstpage_image] =>[orig_patent_app_number] => 09766365 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/766365
Methods and formulations for reducing circulating antibodies Jan 17, 2001 Abandoned
Array ( [id] => 6340685 [patent_doc_number] => 20020034507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Inhibitor of lymphocyte activation' [patent_app_type] => new [patent_app_number] => 09/760723 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12132 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034507.pdf [firstpage_image] =>[orig_patent_app_number] => 09760723 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/760723
Inhibitor of lymphocyte activation Jan 16, 2001 Abandoned
09/701545 Groups of genes expressed in human dendritic cells Jan 10, 2001 Abandoned
Array ( [id] => 6896147 [patent_doc_number] => 20010026937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Monocyte-derived dendritic cell subsets' [patent_app_type] => new [patent_app_number] => 09/760388 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28277 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20010026937.pdf [firstpage_image] =>[orig_patent_app_number] => 09760388 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/760388
Monocyte-derived dendritic cell subsets Jan 9, 2001 Abandoned
Array ( [id] => 1129402 [patent_doc_number] => 06787154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Artificial antigen presenting cells' [patent_app_type] => B2 [patent_app_number] => 09/756983 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 79 [patent_no_of_words] => 42826 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787154.pdf [firstpage_image] =>[orig_patent_app_number] => 09756983 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/756983
Artificial antigen presenting cells Jan 8, 2001 Issued
Array ( [id] => 7118339 [patent_doc_number] => 20010001663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-24 [patent_title] => 'Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component' [patent_app_type] => new-utility [patent_app_number] => 09/756125 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7641 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20010001663.pdf [firstpage_image] =>[orig_patent_app_number] => 09756125 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/756125
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component Jan 8, 2001 Issued
Array ( [id] => 6889367 [patent_doc_number] => 20010024822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Method for inducing immunosuppressive cells and a culture device to be used therefor' [patent_app_type] => new [patent_app_number] => 09/756214 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6542 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20010024822.pdf [firstpage_image] =>[orig_patent_app_number] => 09756214 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/756214
Method for inducing immunosuppressive cells and a culture device to be used therefor Jan 8, 2001 Abandoned
Array ( [id] => 6624670 [patent_doc_number] => 20020086276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands' [patent_app_type] => new [patent_app_number] => 09/750973 [patent_app_country] => US [patent_app_date] => 2000-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16880 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086276.pdf [firstpage_image] =>[orig_patent_app_number] => 09750973 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/750973
Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands Dec 27, 2000 Abandoned
Array ( [id] => 6774171 [patent_doc_number] => 20030017509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus' [patent_app_type] => new [patent_app_number] => 09/735422 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7944 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017509.pdf [firstpage_image] =>[orig_patent_app_number] => 09735422 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/735422
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus Dec 11, 2000 Abandoned
Array ( [id] => 6306097 [patent_doc_number] => 20020094545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads' [patent_app_type] => new [patent_app_number] => 09/726883 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3657 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094545.pdf [firstpage_image] =>[orig_patent_app_number] => 09726883 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/726883
Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads Nov 29, 2000 Abandoned
Array ( [id] => 7625336 [patent_doc_number] => 06723833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent' [patent_app_type] => B1 [patent_app_number] => 09/716028 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 52821 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723833.pdf [firstpage_image] =>[orig_patent_app_number] => 09716028 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/716028
Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent Nov 16, 2000 Issued
Array ( [id] => 741987 [patent_doc_number] => 07030228 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby' [patent_app_type] => utility [patent_app_number] => 09/714712 [patent_app_country] => US [patent_app_date] => 2000-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 34460 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030228.pdf [firstpage_image] =>[orig_patent_app_number] => 09714712 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/714712
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby Nov 14, 2000 Issued
09/713098 Mammalian genes; related reagents and methods Nov 13, 2000 Abandoned
Array ( [id] => 1170413 [patent_doc_number] => 06749852 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion' [patent_app_type] => B1 [patent_app_number] => 09/709249 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4582 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/749/06749852.pdf [firstpage_image] =>[orig_patent_app_number] => 09709249 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/709249
Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion Nov 9, 2000 Issued
09/710249 Recombinant gelatins in vaccines Nov 9, 2000 Abandoned
09/706301 Oil adjuvant vaccine Nov 2, 2000 Abandoned
Menu